Dolby Laboratories, Inc.Class A

DLBNYSECIK 1308547Financial / Asset Managementfiscal year ends September69 quarters since 2009

Revenue, Q3 FY2026
$305M
−3.3% on Q3 FY2025
Net income
$29M
−37.9% on Q3 FY2025
Free cash flow
$152M
+148.9% on Q3 FY2025
Diluted EPS
$0.30
−37.5% on Q3 FY2025
Revenue, TTM
$1.4B
trailing four quarters
Net margin, TTM
16.7%
net income $226M
Free cash flow, TTM
$393M
$438M less $45M capex
Cash and equivalents
$669M
long-term debt —, Jun 26, 2026
Shares, 12-month change
−2.5%
95M diluted weighted shares (no single count on the cover), Jun 26, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$134M
2.2% of market value
Market value
$6.0B
at the close, buybacks

Latest quarter Q3 FY2026, filed July 30, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended June 26, 2026, Dolby Laboratories, Inc.Class A reported revenue of $305M, −3.3% on Q3 FY2025, and net income of $29M (−37.9%). Operating margin was 11.3%. Free cash flow, operating cash flow less capital expenditures, was $152M ($167M less $15M). Diluted earnings per share were $0.30.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

DLB daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $64.91 · H $64.91 · L $61.48 · C $63.61 · −1.52% on the dayOver the range: −3.34%, Nov 14, 2025 to Nov 13, 2026
$47$53$59$65$71Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of July 30, 2026.

Revenue and net incomeRevenueNet income
$0$100M$200M$300M$400MQ4'22, Revenue: $278MQ4'22, Net income: $28MQ4'22Q1'23, Revenue: $335MQ1'23, Net income: $79MQ1'23Q2'23, Revenue: $376MQ2'23, Net income: $96MQ2'23Q3'23, Revenue: $298MQ3'23, Net income: $16MQ3'23Q4'23, Revenue: $291MQ4'23, Net income: $9MQ4'23Q1'24, Revenue: $316MQ1'24, Net income: $67MQ1'24Q2'24, Revenue: $365MQ2'24, Net income: $98MQ2'24Q3'24, Revenue: $289MQ3'24, Net income: $38MQ3'24Q4'24, Revenue: $305MQ4'24, Net income: $59MQ4'24Q1'25, Revenue: $357MQ1'25, Net income: $68MQ1'25Q2'25, Revenue: $370MQ2'25, Net income: $92MQ2'25Q3'25, Revenue: $316MQ3'25, Net income: $46MQ3'25Q4'25, Revenue: $307MQ4'25, Net income: $49MQ4'25Q1'26, Revenue: $347MQ1'26, Net income: $53MQ1'26Q2'26, Revenue: $396MQ2'26, Net income: $95MQ2'26Q3'26, Revenue: $305MQ3'26, Net income: $29MQ3'26$0$100M$200M$300M$400MQ4'22, Revenue: $278MQ4'22, Net income: $28MQ4'22Q1'23, Revenue: $335MQ1'23, Net income: $79MQ1'23Q2'23, Revenue: $376MQ2'23, Net income: $96MQ2'23Q3'23, Revenue: $298MQ3'23, Net income: $16MQ3'23Q4'23, Revenue: $291MQ4'23, Net income: $9MQ4'23Q1'24, Revenue: $316MQ1'24, Net income: $67MQ1'24Q2'24, Revenue: $365MQ2'24, Net income: $98MQ2'24Q3'24, Revenue: $289MQ3'24, Net income: $38MQ3'24Q4'24, Revenue: $305MQ4'24, Net income: $59MQ4'24Q1'25, Revenue: $357MQ1'25, Net income: $68MQ1'25Q2'25, Revenue: $370MQ2'25, Net income: $92MQ2'25Q3'25, Revenue: $316MQ3'25, Net income: $46MQ3'25Q4'25, Revenue: $307MQ4'25, Net income: $49MQ4'25Q1'26, Revenue: $347MQ1'26, Net income: $53MQ1'26Q2'26, Revenue: $396MQ2'26, Net income: $95MQ2'26Q3'26, Revenue: $305MQ3'26, Net income: $29MQ3'26$0$100M$200M$300M$400MQ4'22, Revenue: $278MQ4'22, Net income: $28MQ1'23, Revenue: $335MQ1'23, Net income: $79MQ1'23Q2'23, Revenue: $376MQ2'23, Net income: $96MQ3'23, Revenue: $298MQ3'23, Net income: $16MQ3'23Q4'23, Revenue: $291MQ4'23, Net income: $9MQ1'24, Revenue: $316MQ1'24, Net income: $67MQ1'24Q2'24, Revenue: $365MQ2'24, Net income: $98MQ3'24, Revenue: $289MQ3'24, Net income: $38MQ3'24Q4'24, Revenue: $305MQ4'24, Net income: $59MQ1'25, Revenue: $357MQ1'25, Net income: $68MQ1'25Q2'25, Revenue: $370MQ2'25, Net income: $92MQ3'25, Revenue: $316MQ3'25, Net income: $46MQ3'25Q4'25, Revenue: $307MQ4'25, Net income: $49MQ1'26, Revenue: $347MQ1'26, Net income: $53MQ1'26Q2'26, Revenue: $396MQ2'26, Net income: $95MQ3'26, Revenue: $305MQ3'26, Net income: $29MQ3'26

Net income losses drawn in red.

Free cash flow
$0$50M$100M$150M$200MQ4'22, Free cash flow: $41MQ4'22Q1'23, Free cash flow: $49MQ1'23Q2'23, Free cash flow: $97MQ2'23Q3'23, Free cash flow: $114MQ3'23Q4'23, Free cash flow: $77MQ4'23Q1'24, Free cash flow: $2MQ1'24Q2'24, Free cash flow: $172MQ2'24Q3'24, Free cash flow: $14MQ3'24Q4'24, Free cash flow: $109MQ4'24Q1'25, Free cash flow: $100MQ1'25Q2'25, Free cash flow: $168MQ2'25Q3'25, Free cash flow: $61MQ3'25Q4'25, Free cash flow: $107MQ4'25Q1'26, Free cash flow: $50MQ1'26Q2'26, Free cash flow: $83MQ2'26Q3'26, Free cash flow: $152MQ3'26$0$50M$100M$150M$200MQ4'22, Free cash flow: $41MQ4'22Q1'23, Free cash flow: $49MQ1'23Q2'23, Free cash flow: $97MQ2'23Q3'23, Free cash flow: $114MQ3'23Q4'23, Free cash flow: $77MQ4'23Q1'24, Free cash flow: $2MQ1'24Q2'24, Free cash flow: $172MQ2'24Q3'24, Free cash flow: $14MQ3'24Q4'24, Free cash flow: $109MQ4'24Q1'25, Free cash flow: $100MQ1'25Q2'25, Free cash flow: $168MQ2'25Q3'25, Free cash flow: $61MQ3'25Q4'25, Free cash flow: $107MQ4'25Q1'26, Free cash flow: $50MQ1'26Q2'26, Free cash flow: $83MQ2'26Q3'26, Free cash flow: $152MQ3'26$0$50M$100M$150M$200MQ4'22, Free cash flow: $41MQ1'23, Free cash flow: $49MQ1'23Q2'23, Free cash flow: $97MQ3'23, Free cash flow: $114MQ3'23Q4'23, Free cash flow: $77MQ1'24, Free cash flow: $2MQ1'24Q2'24, Free cash flow: $172MQ3'24, Free cash flow: $14MQ3'24Q4'24, Free cash flow: $109MQ1'25, Free cash flow: $100MQ1'25Q2'25, Free cash flow: $168MQ3'25, Free cash flow: $61MQ3'25Q4'25, Free cash flow: $107MQ1'26, Free cash flow: $50MQ1'26Q2'26, Free cash flow: $83MQ3'26, Free cash flow: $152MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$200M$400M$600M$800MQ4'22, Cash and equivalents: $620MQ4'22Q1'23, Cash and equivalents: $626MQ1'23Q2'23, Cash and equivalents: $688MQ2'23Q3'23, Cash and equivalents: $765MQ3'23Q4'23, Cash and equivalents: $745MQ4'23Q1'24, Cash and equivalents: $657MQ1'24Q2'24, Cash and equivalents: $710MQ2'24Q3'24, Cash and equivalents: $742MQ3'24Q4'24, Cash and equivalents: $482MQ4'24Q1'25, Cash and equivalents: $521MQ1'25Q2'25, Cash and equivalents: $627MQ2'25Q3'25, Cash and equivalents: $699MQ3'25Q4'25, Cash and equivalents: $702MQ4'25Q1'26, Cash and equivalents: $644MQ1'26Q2'26, Cash and equivalents: $594MQ2'26Q3'26, Cash and equivalents: $669MQ3'26$0$200M$400M$600M$800MQ4'22, Cash and equivalents: $620MQ4'22Q1'23, Cash and equivalents: $626MQ1'23Q2'23, Cash and equivalents: $688MQ2'23Q3'23, Cash and equivalents: $765MQ3'23Q4'23, Cash and equivalents: $745MQ4'23Q1'24, Cash and equivalents: $657MQ1'24Q2'24, Cash and equivalents: $710MQ2'24Q3'24, Cash and equivalents: $742MQ3'24Q4'24, Cash and equivalents: $482MQ4'24Q1'25, Cash and equivalents: $521MQ1'25Q2'25, Cash and equivalents: $627MQ2'25Q3'25, Cash and equivalents: $699MQ3'25Q4'25, Cash and equivalents: $702MQ4'25Q1'26, Cash and equivalents: $644MQ1'26Q2'26, Cash and equivalents: $594MQ2'26Q3'26, Cash and equivalents: $669MQ3'26$0$200M$400M$600M$800MQ4'22, Cash and equivalents: $620MQ1'23, Cash and equivalents: $626MQ1'23Q2'23, Cash and equivalents: $688MQ3'23, Cash and equivalents: $765MQ3'23Q4'23, Cash and equivalents: $745MQ1'24, Cash and equivalents: $657MQ1'24Q2'24, Cash and equivalents: $710MQ3'24, Cash and equivalents: $742MQ3'24Q4'24, Cash and equivalents: $482MQ1'25, Cash and equivalents: $521MQ1'25Q2'25, Cash and equivalents: $627MQ3'25, Cash and equivalents: $699MQ3'25Q4'25, Cash and equivalents: $702MQ1'26, Cash and equivalents: $644MQ1'26Q2'26, Cash and equivalents: $594MQ3'26, Cash and equivalents: $669MQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed July 30, 2026.

Dolby Laboratories, Inc.Class A income statement, quarterly
Millions of dollarsQ3 FY2026ended Jun 26, 2026filed Jul 30, 2026Q2 FY2026ended Mar 27, 2026filed Apr 30, 2026Q1 FY2026ended Dec 26, 2025filed Jan 29, 2026Q4 FY2025ended Sep 26, 2025filed Nov 18, 2025Q3 FY2025ended Jun 27, 2025filed Jul 31, 2025Q2 FY2025ended Mar 28, 2025filed May 1, 2025Q1 FY2025ended Dec 27, 2024filed Jan 30, 2025Q4 FY2024ended Sep 27, 2024filed Nov 19, 2024YoYQ3 FY2026vs Q3 FY2025
Revenue305396347307316370357305−3.3%
Cost of revenue4045434044364134−8.4%
Gross profit265351303268272334316271−2.5%
Research and development6664696766626769−0.4%
Selling, general and administrative7676707472707069+4.5%
Operating income341136230481088046−28.0%
Other income (expense)97912812613+20.4%
Pretax income441207242561208660−21.1%
Income tax152418(8)928181+62.6%
Net income2995534946926859−37.9%
Diluted EPS ($)0.300.990.55—0.480.940.70—−37.5%
Diluted shares (millions)959697—979797——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed July 30, 2026.

Dolby Laboratories, Inc.Class A balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Jun 26, 2026filed Jul 30, 2026Q2 FY2026ended Mar 27, 2026filed Apr 30, 2026Q1 FY2026ended Dec 26, 2025filed Jan 29, 2026Q4 FY2025ended Sep 26, 2025filed Nov 18, 2025Q3 FY2025ended Jun 27, 2025filed Jul 31, 2025Q2 FY2025ended Mar 28, 2025filed May 1, 2025Q1 FY2025ended Dec 27, 2024filed Jan 30, 2025Q4 FY2024ended Sep 27, 2024filed Nov 19, 2024YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents669594644702699627521482−4.2%
Short-term investments10111——0−14.5%
Total current assets1,3261,4151,4081,3881,3381,3891,2861,194−0.9%
Total assets3,1573,2493,1923,2283,1963,2293,1593,110−1.2%
Total current liabilities416475444438389457442418+7.1%
Long-term debt—————————
Total debt—————————
Total liabilities564622589596582646642623−3.1%
Stockholders’ equity2,5842,6182,5942,6232,6052,5742,5082,477−0.8%
Shares outstanding (millions)—————————

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed July 30, 2026.

Dolby Laboratories, Inc.Class A cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Jun 26, 2026filed Jul 30, 2026Q2 FY2026ended Mar 27, 2026filed Apr 30, 2026Q1 FY2026ended Dec 26, 2025filed Jan 29, 2026Q4 FY2025ended Sep 26, 2025filed Nov 18, 2025Q3 FY2025ended Jun 27, 2025filed Jul 31, 2025Q2 FY2025ended Mar 28, 2025filed May 1, 2025Q1 FY2025ended Dec 27, 2024filed Jan 30, 2025Q4 FY2024ended Sep 27, 2024filed Nov 19, 2024YoYQ3 FY2026vs Q3 FY2025
Operating cash flow167935512368175107116+147.4%
Capital expenditures1595166777+133.2%
Free cash flow (CFO − capex)152835010761168100109+148.9%
Depreciation and amortization2324242222222221+3.1%
Share repurchases656570withheldwithheldwithheldwithheld20—
Dividends paid3434343232323229+7.4%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed November 18, 2025.

Income statement

Dolby Laboratories, Inc.Class A income statement, annual
Millions of dollarsFY2025ended Sep 26, 2025filed Nov 18, 2025FY2024ended Sep 27, 2024filed Nov 19, 2024FY2023ended Sep 29, 2023filed Nov 17, 2023FY2022ended Sep 30, 2022filed Nov 18, 2022FY2021ended Sep 24, 2021filed Nov 17, 2021FY2020ended Sep 25, 2020filed Nov 16, 2020FY2019ended Sep 27, 2019filed Nov 25, 2019FY2018ended Sep 28, 2018filed Nov 15, 2018FY2017ended Sep 29, 2017filed Nov 16, 2017FY2016ended Sep 30, 2016filed Nov 18, 2016FY2015ended Sep 25, 2015filed Nov 24, 2015FY2014ended Sep 26, 2014filed Nov 18, 2014FY2013ended Sep 27, 2013filed Nov 15, 2013FY2012ended Sep 28, 2012filed Nov 15, 2012FY2011ended Sep 30, 2011filed Nov 23, 2011FY2010ended Sep 24, 2010filed Nov 22, 2010FY2009ended Sep 25, 2009filed Jul 29, 2010FY2008ended Sep 26, 2008filed Jul 29, 2010
Revenue1,3491,2741,3001,2541,2811,1621,2421,0551,0801,026971960910933961923720640
Cost of revenue160140153141130146161128119109957097921111326568
Gross profit1,1891,1331,1471,1121,1511,0151,081927962917876890813841850791655572
Research and development2622642722612542392382372332202011831691401241058278
Selling, general and administrative28727025827522422020519717216918217816214913811910698
Operating income265258216207344219257184247232213274245362430429364287
Other income (expense)395434910212513843325711(3)(1)
Pretax income303312250215355240282196255236246276251369441437371302
Income tax47484831378271544850636760104130154127101
Net income25526220118431023125542206186181206189264309283243199
Diluted EPS ($)2.622.692.051.812.972.252.440.392.001.811.751.991.842.462.752.462.111.74
Diluted shares (millions)979798102105103105107103102104104103108113115115115

Balance sheet

Dolby Laboratories, Inc.Class A balance sheet, annual
Millions of dollarsFY2025ended Sep 26, 2025filed Nov 18, 2025FY2024ended Sep 27, 2024filed Nov 19, 2024FY2023ended Sep 29, 2023filed Nov 17, 2023FY2022ended Sep 30, 2022filed Nov 18, 2022FY2021ended Sep 24, 2021filed Nov 17, 2021FY2020ended Sep 25, 2020filed Nov 16, 2020FY2019ended Sep 27, 2019filed Nov 25, 2019FY2018ended Sep 28, 2018filed Nov 15, 2018FY2017ended Sep 29, 2017filed Nov 16, 2017FY2016ended Sep 30, 2016filed Nov 18, 2016FY2015ended Sep 25, 2015filed Nov 24, 2015FY2014ended Sep 26, 2014filed Nov 18, 2014FY2013ended Sep 27, 2013filed Nov 15, 2013FY2012ended Sep 28, 2012filed Nov 15, 2012FY2011ended Sep 30, 2011filed Nov 23, 2011FY2010ended Sep 24, 2010filed Nov 22, 2010FY2009ended Sep 25, 2009filed Jul 29, 2010FY2008ended Sep 26, 2008filed Jul 29, 2010
Cash and equivalents7024827456201,2251,072797918634520532568454493552546452395
Short-term investments101391893947119178248122139231140303391302284—
Total current assets1,3881,1941,4881,3111,7601,5471,3821,4971,0117608211,0068199701,1591,060901—
Total assets3,2283,1102,9802,6903,1062,9172,8222,8652,5342,3102,1331,9841,7381,9611,8841,7121,581—
Total current liabilities438418422278316267307285246213210189173157159166157—
Long-term debt——————————————————
Total debt——————————————————
Total liabilities596623608439501479509495390331317252238218199217218—
Stockholders’ equity2,6232,4772,3552,2462,5982,4332,3072,3642,1371,9701,8071,7101,4811,7201,6641,4741,341—
Shares outstanding (millions)——————————————————

Cash flow statement

Dolby Laboratories, Inc.Class A cash flow statement, annual
Millions of dollarsFY2025ended Sep 26, 2025filed Nov 18, 2025FY2024ended Sep 27, 2024filed Nov 19, 2024FY2023ended Sep 29, 2023filed Nov 17, 2023FY2022ended Sep 30, 2022filed Nov 18, 2022FY2021ended Sep 24, 2021filed Nov 17, 2021FY2020ended Sep 25, 2020filed Nov 16, 2020FY2019ended Sep 27, 2019filed Nov 25, 2019FY2018ended Sep 28, 2018filed Nov 15, 2018FY2017ended Sep 29, 2017filed Nov 16, 2017FY2016ended Sep 30, 2016filed Nov 18, 2016FY2015ended Sep 25, 2015filed Nov 24, 2015FY2014ended Sep 26, 2014filed Nov 18, 2014FY2013ended Sep 27, 2013filed Nov 15, 2013FY2012ended Sep 28, 2012filed Nov 15, 2012FY2011ended Sep 30, 2011filed Nov 23, 2011FY2010ended Sep 24, 2010filed Nov 22, 2010FY2009ended Sep 25, 2009filed Jul 29, 2010FY2008ended Sep 26, 2008filed Jul 29, 2010
Operating cash flow472327367319448344328352378360309362277390404327273264
Capital expenditures3630304854669673100101158752716747371414
Free cash flow (CFO − capex)436297337271393278231279278259152286250223356290259251
Depreciation and amortization887683889691858184856953534444352925
Share repurchases1251601495302461743411501001011075682268192241——
Dividends paid12711510310089897766574841040800———

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$996K
4 sales by 2 insiders; officers and directors $996K
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$15M
38 sales by 9 insiders; officers and directors $15M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Couling John DSVP, Entertainmentoption exercise7,667$45.50$349K174,470Oct 5, 2026
Oct 1, 2026Couling John DSVP, Entertainmentopen-market sale10b5-16,831$58.72$401K167,639Oct 5, 2026
Oct 1, 2026Couling John DSVP, Entertainmentopen-market sale10b5-1836$59.33$50K166,803Oct 5, 2026
Sep 15, 2026Whitten MarcPresident and CEO, Directoraward160,256$0.00—160,256Sep 17, 2026
Sep 15, 2026Couling John DSVP, Entertainmentaward48,076$0.00—166,803Sep 17, 2026
Sep 15, 2026Sherman Mark AndrewEVP, Gen. Counsel & Secretaryaward48,076$0.00—119,024Sep 17, 2026
Sep 1, 2026Couling John DSVP, Entertainmentoption exercise7,667$45.50$349K126,394Sep 3, 2026
Sep 1, 2026Couling John DSVP, Entertainmentopen-market sale10b5-17,667$61.05$468K118,727Sep 3, 2026
Aug 28, 2026Dolby Dagmar+1 more10% ownerconversionindirect300,000$0.00—300,000Aug 28, 2026
Aug 28, 2026Dolby Dagmar+1 more10% ownergiftindirect300,000$0.00—0Aug 28, 2026
Aug 25, 2026Nicholson RyanVP, CAO and Corp. Controlleropen-market sale1,183$65.28$77K34,453Aug 27, 2026
Aug 14, 2026Revankar ShriramSVP, Advanced Technology Groupopen-market sale10b5-13,000$62.71$188K73,274Aug 18, 2026
Aug 10, 2026Nicholson RyanVP, CAO and Corp. Controlleropen-market sale1,348$62.04$84K35,636Aug 12, 2026
Aug 4, 2026Nicholson RyanVP, CAO and Corp. Controlleropen-market sale357$60.63$22K36,984Aug 6, 2026
Aug 3, 2026Couling John DSVP, Entertainmentoption exercise7,667$45.50$349K126,394Aug 5, 2026
Aug 3, 2026Couling John DSVP, Entertainmentopen-market sale10b5-1783$59.03$46K125,611Aug 5, 2026
Aug 3, 2026Couling John DSVP, Entertainmentopen-market sale10b5-16,884$60.11$414K118,727Aug 5, 2026
Jul 1, 2026Couling John DSVP, Entertainmentoption exercise7,667$45.50$349K126,394Jul 6, 2026
Jul 1, 2026Couling John DSVP, Entertainmentopen-market sale10b5-17,667$53.20$408K118,727Jul 6, 2026
Jun 1, 2026Couling John DSVP, Entertainmentoption exercise7,666$45.50$349K126,393Jun 3, 2026
Jun 1, 2026Couling John DSVP, Entertainmentopen-market sale10b5-17,158$55.59$398K119,235Jun 3, 2026
Jun 1, 2026Couling John DSVP, Entertainmentopen-market sale10b5-1508$56.16$29K118,727Jun 3, 2026
May 22, 2026Pendleton ToddSVP, Chief Marketing Officeropen-market sale11,876$54.55$648K41,480May 27, 2026
May 18, 2026Revankar ShriramSVP, Advanced Technology Grouptax withholding4,329$54.21$235K76,274May 19, 2026
May 15, 2026Revankar ShriramSVP, Advanced Technology Groupopen-market sale10b5-13,000$54.90$165K80,603May 19, 2026

Full insider history for Dolby Laboratories, Inc.Class A, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held DLB in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded DLB by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$14M234,9000.02%new

Sources

Fiscal year ends in month 9; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Dolby Laboratories, Inc., CIK 1308547 on EDGAR
Extract generated
November 16, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: buybacks FY2025
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total debt: not filed
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): not filed

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/DLB.json